Loading...
*  A Randomized Trial of Recombinant Staphylokinase Versus Alteplase for Coronary Artery Patency in Acute Myocardial Infarction |...
6 7 An important difference between these fibrinolytic agents is that RTPA is fibrinogen-sparing.12 At pharmacological dosages ... Both agents were given intravenously. RTPA (Actilyse, Boehringer Ingelheim) was administered according to an accelerated and ... PTCA or additional thrombolysis with a commercially available agent at 90 minutes to 24 hours was allowed if TIMI grade 0 or 1 ... Restoration of coronary artery flow by thrombolytic agents administered early in the course of an evolving MI salvages ...
http://circ.ahajournals.org/content/92/8/2044
*  Welcome to CDC stacks | Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic...
Fibrinolytic Agents Hospital Mortality Humans Intracranial Hemorrhages Male Middle Aged Myocardial Ischemia Prognosis ...
https://stacks.cdc.gov/view/cdc/31394
*  Endothelium-Dependent Vasodilation and Tissue-Type Plasminogen Activator Release in Borderline Hypertension | Arteriosclerosis,...
The fibrinolytic response of man to vasoactive drugs measured in arterial blood. Thromb Res.. 1978;13:419-428. ... The vascular endothelium produces a number of agents with effects on vascular smooth muscle cell tone and hemostatic function,1 ... Unfortunately, in most previous studies on fibrinolytic function in hypertension, metabolic data have not been presented.40 41 ... Table 3⇓ shows the net kinetics of fibrinolytic factors across the forearm at baseline. Both groups showed a positive ...
http://atvb.ahajournals.org/content/17/12/3376
*  Computed tomography scan following thrombolytic therapy | Open-i
The current study describes the fibrinolytic treatment of a patient exhibiting an acute massive pulmonary thromboembolism, who ... However, there is insufficient data regarding the safety and activity of thrombolytic agents in cancer patients receiving ... The current study describes the fibrinolytic treatment of a patient exhibiting an acute massive pulmonary thromboembolism, who ... However, there is insufficient data regarding the safety and activity of thrombolytic agents in cancer patients receiving ...
https://openi.nlm.nih.gov/detailedresult.php?img=PMC4214487_OL-08-06-2779-g01&req=4
*  The regulation by fibrinogen and fibrin of tissue plasminogen activator kinetics and inhibition by plasminogen activator...
Development of a new test for the global fibrinolytic capacity in whole blood, Journal of Thrombosis and Haemostasis, 2007, 6, ... Advertisers & Agents Powered by Wiley Online Library. Copyright © 1999 - 2017 John Wiley & Sons, Inc. All Rights Reserved ...
http://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2007.02422.x/abstract
*  Patent US20060246053 - Pharmaceutical compositions of fibrinolytic agent - Google Patents
Frozen and lyophilized compositions for a metalloproteinase fibrinolytic agent (fibrolase or NAT), a method for preparing the ... Frozen and lyophilized compositions for a metalloproteinase fibrinolytic agent (fibrolase or NAT), a method for preparing the ... Frozen and lyophilized compositions for a metalloproteinase fibrinolytic agent (fibrolase or NAT), a method for preparing the ... The present invention relates to novel pharmaceutical compositions of a fibrinolytic agent. More specifically, the present ...
http://www.google.com.au/patents/US20060246053
*  FIBRINOLYTIC AGENTS | Pharmacological agents | Medicinal Plants
FIBRINOLYTIC AGENTS. 2014 FIBRINOLYTIC AGENTS help in the dissolution of thrombi or blood clots. Some agents used clinically ... Turning to extrinsic fibrinolytic agents used medically to enhance or mimic the normal fibrinolytic processes, and dissolve ... Regarding intrinsic fibrinolytic factors in the body, when the intrinsic' coagulation system is activated, the fibrinolytic ... It is often beneficial to give agents from two or three of these classes in concert (vide infra). ...
http://medicinalplants.us/fibrinolytic-agents
*  Caverject - Fibrinolytic Agents, Platelet Aggregation Inhibitors, Vasodilator Agents, ATC:C01EA01, ATC...
Alprostadil (prostaglandin E1) is produced endogenously to relax vascular smooth muscle and cause vasodilation. In adult males, the vasodilatory effects of alprostadil on the cavernosal arteries and the trabecular smooth muscle of the corpora cavernosa result in rapid arteriolar inflow and expansion of the lacunar spaces within the corpora. As the expanded corporal sinusoids are compressed against the tunica albuginea, venous outflow through the subtunical vessels is impeded and penile rigidity develops. This is referred to as the corporal veno-occlusive mechanism. In infants, the vasodilatory effects of alprostadil increase pulmonary or systemic blood flow ...
http://pharmacycode.com/Caverject.html
*  Apitherapy News: Bee Venom Peptide is Anti-Fibrinolytic, Anti-Microbial Agent
Bee Venom Peptide is Anti-Fibrinolytic, Anti-Microbial Agent Secapin, a bee venom peptide, exhibits anti-fibrinolytic, anti- ... venom peptide secapin has multifunctional roles as an anti-fibrinolytic agent during fibrinolysis and an anti-microbial agent ... thus indicating the role of AcSecapin-1 as an anti-fibrinolytic agent. AcSecapin-1 also inhibited both human neutrophil and ... Here, we provide the evidence that Asiatic honeybee (Apis cerana) secapin (AcSecapin-1) exhibits anti-fibrinolytic, anti- ...
http://apitherapy.blogspot.com/2016/05/bee-venom-peptide-is-anti-fibrinolytic.html
*  Anticoagulant and Fibrinolytic Drugs - Possible Agents in Treatment of Lung Cancer? | Bentham Science
Anti-Cancer Agents in Medicinal Chemistry. Title:Anticoagulant and Fibrinolytic Drugs - Possible Agents in Treatment of Lung ... Vladimir Bobek, "Anticoagulant and Fibrinolytic Drugs - Possible Agents in Treatment of Lung Cancer?", Anti-Cancer Agents in ... Anticoagulant and Fibrinolytic Drugs - Possible Agents in Treatment of Lung Cancer?. Author(s): Vladimir Bobek. 3rd Faculty of ... The aim of this study is to review anticoagulant and fibrinolytic drugs as antitumor agents with focus on their clinical use. ...
http://www.eurekaselect.com/98185/article?tracking-code=4
*  Acute Coronary Syndrome: Current Treatment - - American Family Physician
... patients with ST elevation myocardial infarction can be treated with fibrinolytic therapy. Fibrinolysis is not recommended in ... Fibrinolytic Agents. Fibrinolytic agent. Dose. Fibrin specificity*. Antigenic. Patency rate (90-minute TIMI 2 or 3 flow). ... Fibrinolytic Agents. Fibrinolytic agent. Dose. Fibrin specificity*. Antigenic. Patency rate (90-minute TIMI 2 or 3 flow). ... 4 The ACCF/AHA guideline recommends using a fibrin-specific fibrinolytic agent. Table 3 lists fibrinolytic agents currently ...
https://www.aafp.org/afp/2017/0215/p232.html
*  ICS-STEMI Flashcards by Rebecca Andersen | Brainscape
2. Should be performed within 90 minutes of first medical contact (otherwise fibrinolytic therapy is preferred). ... initiate thrombolysis by converting plasminogen to plasmin (a fibrinolytic enzyme that dissolves the fibrin clot) ... Recommendation for Short-term use of clopidogrel in STEMI patients who receive fibrinolytic therapy, aspirin and ...
https://www.brainscape.com/flashcards/ics-stemi-2714301/packs/4652385
*  Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST...
Fibrinolytic Agents. Grant support. *T32HL076136/HL/NHLBI NIH HHS/United States. *T32 HL076136-05/HL/NHLBI NIH HHS/United ...
https://www.ncbi.nlm.nih.gov/pubmed/19332194
*  Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI) - Full Text View - ClinicalTrials.gov
Fibrinolytic Agents. Fibrin Modulating Agents. Molecular Mechanisms of Pharmacological Action. To Top ... PMX-60056 is being developed as a rapid and effective reversal agent for use in those situations where anticoagulation by ...
https://www.clinicaltrials.gov/ct2/show/NCT01312935?map_cntry=US&map_state=US%3ASD&rank=87
*  Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components -...
... anti-emetic agents; anti-epileptic agents; anti-estrogen agents; anti-fibrinolytic agents; anti-fungal agents; anti-glaucoma ... anti-acne agents; anti-adrenergic agents; anti-allergic agents; anti-amebic agents; anti-androgen agents; anti-anemic agents; ... anabolic agents; analeptic agents; analgesic agents; androgenic agents; anesthetic agents; anorectic compounds; anorexic agents ... anti-spasmodic agents; anti-tartar and anti-calculus agents; anti-thrombotic agents; anti-tubercular agents; antitussive agents ...
http://www.freepatentsonline.com/y2005/0113510.html
*  Myocardial Infarction Medication: Antiplatelet Agents, Antithrombotic Agents, Glycoprotein IIb/IIIa Inhibitors, Vasodilators,...
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and ... Antiplatelet Agents. Class Summary. Antiplatelet agents have a strong mortality benefit. There is an increased risk of bleeding ... Antithrombotic Agents. Class Summary. Antithrombotic agents, which include heparin, bivalirudin, and enoxaparin, prevent the ... Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial ...
https://emedicine.medscape.com/article/155919-medication
*  Free Pharmacology Flashcards about chapters 11-17
fibrinolytic agents. Which of the following drugs is an inhibitor of angiotensin-converting enzyme and is used to treat ... Which fibrinolytic agent below binds to fibrin, converts plasminogen to plasmin, and is incompatible with dextrose?. ... What reversal agent may be used to treat respiratory depression caused by an opioid (narcotic) overdose?. naloxone (Narcan). ... What bioterrorism agent is derived from castor beans, inhibits protein synthesis, and has no known treatment?. ricin. ...
https://www.studystack.com/flashcard-39872
*  Red Sage | GreenMedInfo | Substance | Natural Medicine | Alternative
Pharmacological Actions : Fibrinolytic Agents. [+] Red sage increases dopamine release in an in vitro study. Mar 01, 2006. ... Pharmacological Actions : Antihypertensive Agents, Vascular Endothelial Growth Factor Regulator. Additional Keywords : Drug: ... Pharmacological Actions : Anti-Apoptotic, Anti-Inflammatory Agents, Antioxidants, Interleukin-6 Downregulation, Tumor Necrosis ... Salvianolic acid A might be a promising therapeutic agent for the treatment of diabetic nephropathy.Dec 31, 2016. ...
http://www.greenmedinfo.com/substance/red-sage
*  Nattokinase | GreenMedInfo | Substance | Natural Medicine
Pharmacological Actions : Fibrinolytic Agents. Additional Keywords : Thrombolytic. [+] Nattokinase could be a good candidate ...
http://www.greenmedinfo.com/substance/nattokinase